Continurd.

All Cadaveric Kidney Transplant Recipients (n = 20,111)Univariate OR (95% CI) for DHCV+Adjusted OR (95% CI) for DHCV+dAdjusted OR (95% CI) for DHCV+/HCV Recipiente
a Results given as % (n) or mean ± SD. Adjustment by logistic regression analysis, forward step likelihood ratio method, covariates as specified in the Materials and Methods section. CMV, cytomegalovirus; PRA, panel reactive antibody.
b Expressed as percentage of donor HCV+ kidneys transplanted in each state compared with the total number of kidneys transplanted in that state, followed by (in parentheses) the absolute number of donor HCV+ kidney transplants in that state.
c Available only for patients starting ESRD therapy on or after April 1, 1995, n = 6516, donor HCV+, n = 177.
d Strength of association (by stepwise logistic regression analysis) of factors associated with receiving a hepatitis C--positive kidney (1) versus receiving a hepatitis C--negative kidney (0), independent of other factors in the model.
e Strength of association (by stepwise logistic regression analysis) of factors associated with a hepatitis C--negative recipient transplanted with a hepatitis C-positive kidney (1) versus all other recipients (0), independent of other factors in the model.
    North Carolina1.5% (7)0.04 (0.00 to 0.47)
    Florida0.4% (5)0.04 (0.01 to 0.26).07 (.006 to 0.80)
    Tennessee2.1% (9)0.08 (0.01 to 0.66)
    Texas1.4% (21)0.08 (0.01 to 0.43)
Year of transplant (per more recent year)0.87 (0.77 to 0.98)0.84 (0.73 to 0.98)
Maintenance medications
    cyclosporine79.6% (15,801)0.64 (0.53 to 0.78)
    tacrolimus11.4% (2155)1.71 (1.36 to 2.15)
    azathioprine43.1% (8208)0.70 (0.51 to 0.85)
    mycophenolate46.4 (8870)1.21 (1.01 to 1.44)
Antibody induction (Y/N)43.5% (8758)NS
Comorbidities from Medical Evidence Form 2728c
    chronic obstructive pulmonary disease1.5% (96)2.89 (1.32 to 6.34)2.69 (1.14 to 6.32)
    drug use0.4% (28)14.96 (6.50 to 34.40)8.95 (3.32 to 24.11)
    ischemic heart disease7.7% (500)0.64 (0.32 to 1.26)0.42 (0.20 to 0.92)
    hypertension72.3% (4713)0.74 (0.54 to 1.01)0.61 (0.44 to 0.86)
    congestive heart failure9.8% (641)1.76 (1.16 to 2.65)
    smoking5.8% (380)1.87 (1.14 to 3.08)
    alcohol use0.8% (49)3.23 (1.15 to 9.09)